Compare AEMD & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEMD | VERO |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 4.0M |
| IPO Year | N/A | N/A |
| Metric | AEMD | VERO |
|---|---|---|
| Price | $3.40 | $1.87 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $287.50 | N/A |
| AVG Volume (30 Days) | ★ 118.1K | 36.1K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $58,876,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.21 | $1.65 |
| 52 Week High | $84.40 | $14.50 |
| Indicator | AEMD | VERO |
|---|---|---|
| Relative Strength Index (RSI) | 44.54 | 46.16 |
| Support Level | $3.21 | $1.84 |
| Resistance Level | $4.09 | $1.99 |
| Average True Range (ATR) | 0.39 | 0.12 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 11.11 | 44.78 |
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.